Zhongqing Zou
P.R. China
Chengdu, 610000, China
Chengdu, 610000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and safety of blinatumomab combination therapy in high-risk B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.
Journal: Oncology letters
Published: November 08, 2025
Correction: Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma.
Journal: Frontiers in immunology
Published: July 28, 2025
Venetoclax plus decitabine, cytarabine, aclarubicin, and G-CSF in adults with newly diagnosed acute myeloid leukemia: A multicenter, retrospective study.
Journal: International journal of cancer
Published: June 19, 2025
Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.
Journal: International journal of cancer
Published: April 04, 2025
Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma.
Journal: Frontiers in immunology
Published: February 03, 2025
Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era.
Journal: Clinical and experimental medicine
Published: July 17, 2024
Erratum: Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum.
Journal: Journal of Cancer
Published: December 09, 2022
A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma.
Journal: Cancer medicine
Published: October 10, 2021
Predictive Values of PET/CT in Combination With Regulatory B Cells for Therapeutic Response and Survival in Contemporary Patients With Newly Diagnosed Multiple Myeloma.
Journal: Frontiers in immunology
Published: February 24, 2021
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China.
Journal: Journal of Cancer
Published: September 13, 2020
Low-dose ruxolitinib shows effective in treating myelofibrosis.
Journal: Annals of hematology
Published: August 16, 2020
Aberrant TRPM4 expression in MLL-rearranged acute myeloid leukemia and its blockade induces cell cycle arrest via AKT/GLI1/Cyclin D1 pathway.
Journal: Cellular signalling
Published: January 06, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026